Hjem › Kræft (alle typer) › Texas › Austin
Kræft (alle typer) kliniske forsøg i Austin, TX
20 studier for Kræft (alle typer) søger deltagere på steder i og omkring Austin (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekruttererFase 2
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RekruttererFase 3
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RekruttererFase 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
RekruttererObservationsstudie
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RekruttererFase 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekruttererFase 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
RekruttererFase 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RekruttererFase 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
RekruttererFase 1/2
- NEXT Oncology Austin, Austin
Kræft (alle typer) forsøg i andre byer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Seattle, WA49 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
Andre studier i Austin
- Ikke-småcellet lungecancer30 studier
- Overvægt20 studier
- Metastatisk cancer19 studier
- Colorektal kræft19 studier
- Hjertesvigt18 studier
- Brystkræft18 studier
- Overvægt18 studier
- Ægstockræft17 studier
- Livmoderslimhindekræft15 studier
- Prostatakræft15 studier
- Depression14 studier
- Tripelnegativ brystkræft13 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.